Insider Buy/Sell Details for the Biotechnology Industry — June 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1527)
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
24,565
Price
$0.37
Total Value
$9.09K
Shares Held After
381,717
% of Holdings
6.0%
Werewolf Therapeutics, Inc. (HOWL)
RA CAPITAL MANAGEMENT, L.P. — 10% Owner
Shares
345,235
Price
$0.37
Total Value
$127.74K
Shares Held After
5,364,623
% of Holdings
6.0%
Nuvation Bio Inc. (NUVB)
Mashal Robert — Director
Shares
25,000
Price
$4.73
Total Value
$118.25K
Shares Held After
225,000
% of Holdings
11.1%
Artiva Biotherapeutics, Inc. (ARTV)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
479,039
Price
$6.91
Total Value
$3.31M
Shares Held After
15,683,034
% of Holdings
3.1%
Shattuck Labs, Inc. (STTK)
SIEGALL CLAY B — Director
Shares
62,500
Price
$4.00
Total Value
$250.00K
Shares Held After
318,608
% of Holdings
19.6%
Nuvalent, Inc. (NUVL)
Noci Darlene — Chief Development Officer
Shares
20,000
Price
$122.81
Total Value
$2.46M
Shares Held After
58,117
% of Holdings
25.6%
GYRE THERAPEUTICS, INC. (GYRE)
Ye Weiguo — Chief Operating Officer
Shares
14,500
Price
$6.14
Total Value
$89.03K
Shares Held After
700,000
% of Holdings
2.0%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
878,659
Price
$0.03
Total Value
$29.00K
Shares Held After
314,674
% of Holdings
73.6%
Axsome Therapeutics, Inc. (AXSM)
Mahony Susan — Director
Shares
300
Price
$237.21
Total Value
$71.16K
Shares Held After
1,129
% of Holdings
21.0%
Aditxt, Inc. (ADTX)
Gong Sandie — 10% Owner
Shares
100,000
Price
$0.07
Total Value
$6.88K
Shares Held After
0
% of Holdings
100.0%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
12,992
Price
$4.06
Total Value
$52.75K
Shares Held After
154,339
% of Holdings
7.8%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
76,928
Price
$0.37
Total Value
$28.46K
Shares Held After
300,283
% of Holdings
20.4%
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
ORESHACK KURT — General Counsel
Shares
25,000
Price
$5.06
Total Value
$126.50K
Shares Held After
360,767
% of Holdings
6.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$552.89
Total Value
$121.64K
Shares Held After
40,513
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,760
Price
$552.45
Total Value
$1.52M
Shares Held After
40,733
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$551.35
Total Value
$727.78K
Shares Held After
43,493
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$549.77
Total Value
$263.89K
Shares Held After
44,813
% of Holdings
1.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
280
Price
$548.84
Total Value
$153.67K
Shares Held After
45,293
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,499
Price
$547.67
Total Value
$820.95K
Shares Held After
45,573
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,534
Price
$546.66
Total Value
$838.58K
Shares Held After
47,072
% of Holdings
3.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
916
Price
$545.66
Total Value
$499.83K
Shares Held After
48,606
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
491
Price
$544.69
Total Value
$267.44K
Shares Held After
49,522
% of Holdings
1.0%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
8,034
Price
$65.24
Total Value
$524.16K
Shares Held After
1,564,407
% of Holdings
0.5%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
64,500
Price
$64.27
Total Value
$4.15M
Shares Held After
1,572,441
% of Holdings
3.9%
Acumen Pharmaceuticals, Inc. (ABOS)
Fountain Nathan B — Director
Shares
6,400
Price
$2.23
Total Value
$14.27K
Shares Held After
48,150
% of Holdings
11.7%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
31,916
Price
$5.30
Total Value
$169.29K
Shares Held After
1,374,079
% of Holdings
2.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
5,450
Price
$5.30
Total Value
$28.91K
Shares Held After
303,451
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
6,305
Price
$5.30
Total Value
$33.44K
Shares Held After
440,003
% of Holdings
1.4%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
25,646
Price
$5.39
Total Value
$138.29K
Shares Held After
518,437
% of Holdings
4.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
13,421
Price
$5.30
Total Value
$71.19K
Shares Held After
544,083
% of Holdings
2.4%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
5,000
Price
$0.85
Total Value
$4.25K
Shares Held After
298,266
% of Holdings
1.7%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$67.98
Total Value
$237.93K
Shares Held After
153,902
% of Holdings
2.2%
Tonix Pharmaceuticals Holding Corp. (TNXP)
LEDERMAN SETH — Director
Shares
5,000
Price
$11.79
Total Value
$58.95K
Shares Held After
9,005
% of Holdings
55.5%
Axsome Therapeutics, Inc. (AXSM)
TABUTEAU HERRIOT — Director
Shares
49,670
Price
$241.01
Total Value
$11.97M
Shares Held After
7,229
% of Holdings
87.3%
Axsome Therapeutics, Inc. (AXSM)
Pizzie Nick — Chief Financial Officer
Shares
33,000
Price
$240.09
Total Value
$7.92M
Shares Held After
42,867
% of Holdings
43.5%
Aditxt, Inc. (ADTX)
HRT FINANCIAL LP — 10% Owner
Shares
1,423,493
Price
$0.05
Total Value
$69.75K
Shares Held After
1,193,333
% of Holdings
119.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
2,982
Price
$1.52
Total Value
$4.53K
Shares Held After
72,535
% of Holdings
4.1%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
29,518
Price
$1.52
Total Value
$44.87K
Shares Held After
718,444
% of Holdings
4.1%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
5,893
Price
$4.38
Total Value
$25.81K
Shares Held After
167,331
% of Holdings
3.4%
INSMED Inc (INSM)
Lewis William — Director
Shares
6,515
Price
$94.03
Total Value
$612.61K
Shares Held After
258,917
% of Holdings
2.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,120
Price
$271.14
Total Value
$303.68K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,820
Price
$270.38
Total Value
$1.03M
Shares Held After
1,120
% of Holdings
77.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
36
Price
$272.08
Total Value
$9.79K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
100
Price
$271.06
Total Value
$27.11K
Shares Held After
36
% of Holdings
73.5%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
40
Price
$270.55
Total Value
$10.82K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,444
Price
$269.33
Total Value
$388.92K
Shares Held After
40
% of Holdings
97.3%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
160
Price
$271.26
Total Value
$43.40K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
711
Price
$270.24
Total Value
$192.14K
Shares Held After
160
% of Holdings
81.6%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
40
Price
$270.73
Total Value
$10.83K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,327
Price
$269.34
Total Value
$357.42K
Shares Held After
40
% of Holdings
97.1%
Showing 651–700 of 1527 transactions (page 14 of 31)